Quantcast
Channel: MoneyScience: All site news items
Viewing all articles
Browse latest Browse all 3742

Rhythm Expands Scientific Advisory Board for Clinical Programs in Metabolic Diseases

$
0
0
BOSTON, July 26, 2011 /PRNewswire/ -- Rhythm announced today three appointments to its Scientific Advisory Board to work with the company on its clinical development programs in metabolic diseases: John M. Amatruda, MD, formerly Franchise Head of Diabetes and Obesity at Merck; Michael C. Camilleri,

Viewing all articles
Browse latest Browse all 3742

Trending Articles